An expression vector is also called an expression construct and is usually a plasmid derivative designed for protein expression in cells.Protein expression refers to the technique in which proteins are regulated, modified and synthesized in living organisms or cells.For use in biotechnology products and proteinproduction,expression vectors are the basic tools. For example, insulin is used in diabetes. An expression vector has features such as a selectable marker, origin of replication, and a suitable site for the insertion of a gene (multiple cloning site). An expression vector must have necessary elements such as strong promoter, initiation sequence and a transcription termination sequence.Advancement in protein expression and introduction of advanced technologies in the field of genetics, molecular biology, genetic engineering and computer sciences drives the growth of expression vector market. Some medical applications of protein expression include the large scale production of human insulin and various other protein based products. Major protein expression systems include, mammalian cell expression systems, baculovirus based systems, K. lactis systems, E. coli systems, saccharomyces systems, Pichia systems and others.
Geographically, the global expression vectors market is analyzed by various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Rest of the World. North America dominates the global market followed by Europe due to increasing scientific research and development of novel technologies in this region. In addition, increasing investment of U.S. government and private companies in synthetic biology research indirectly accentuates the growth of this market.Asia-Pacific is the fastest growing expression vector market owing to increasing penetration of various pharmaceutical giants and biotechnology in R&D activities in these areas. Other main factors accountable for this regions’ fast growth are rapidly growing healthcare infrastructure and rising awareness and demand for biologics and other proteins in the region.
Globally, the factors driving the growth of expression vectors market include high prevalence of lifestyle diseases, infectious diseases, the increasing demand of protein-based drugs (biologics) genetic disorders, and increasing funding for protein research. Furthermore,Sales drop in the pharmaceutical industry due to current patent expiries of major drugs hasmanifested intense research and development of novel pharmaceuticals in various categories that demands more proteins from this market, therefore it is likely to contribute towards the growth of this market. On the other hand, factors such as high market competition with entry barriers, and high cost of protein therapy are some of the major factors restraining the growth of expression vector market.Increasing government support for developing safe and effective protein therapeutics; along with high research and development initiatives in advanced diagnostic techniques are expected to fuel the growth of this market. Additionally, technological advancements in the field of in vitro diagnostics and increased focus on retaining superior quality of life are some of the factors that might contribute to the growth of this market. However, high R&D cost and product approval are some of the factors that might negatively influence the growth of expression vector market.
The global expression vector market is highly competitive and mature due to the participation and presence of many established as well as new players in this market.Some of the key global participants present in the expression vector market include Thermo Fisher Scientific, Inc., Sigma-Aldrich Corporation, Agilent Technologies, Promega Corporation, Bio-Rad Laboratories, New England Biolabs, Life Technologies Corporation, Clontech Laboratories, Inc., Merck Millipore, QIAGEN, GenScript USA Inc.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Middle East and Africa
- Latin America
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.